Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Eagle Pharmaceuticals, Inc. to Present at September Investor Conferences

Eagle Pharmaceuticals,Inc.
Posted on: 06 Sep 17

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or “the Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at two investor conferences in September as follows:

Conference:     Morgan Stanley 15th Annual Global Healthcare Conference
Date: Wednesday, September 13, 2017
Time: 8:45 a.m. Eastern Daylight Time
Location: Grand Hyatt New York, New York

Conference:     Cantor Fitzgerald Global Healthcare Conference
Date: Monday, September 25, 2017
Time: 9:10 a.m. Eastern Daylight Time
Location: InterContinental New York Barclay Hotel, New York


The presentations will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the Company’s website at

View source version on

Business Wire

Last updated on: 06/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.